(2-CHLORO-PHENYL)-DIMETHYLAMINO-ACETIC ACID, 95.0%, 250mg

Recipientes esterilizables en autoclave con tapa rectangular, 114 l, 1 unidad

tert-butyl (2R,4S)-2,4-bis(iodomethyl)azetidine-1-carboxylate, 98%, 250mg

N~1~-(3-amino-4-methylphenyl)-N~2~,N~2~-dimethylglycinamide dihydrochloride, 95.0%, 5g

(1-(2-Aminophenyl)piperidin-4-yl)methanol, 97%, 250mg

(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid, 97%, 5g

1-(3-bromobenzoyl)-1,4-diazepane, 95.0%, 2g

{3-[(2-methyl-2-propen-1-yl)oxy]phenyl}methanol, 95.0%, 1g

4'-iso-Butylpropiophenone, 95.0%, 1g

6-(4-((5-CHLORO-4-((4-CHLOROPHENYL)AMINO)PYRIMIDIN-2-YL)AMINO)-1H-PYRAZOL-1-YL)-N-HYDROXYHEXANAMIDE, 95%, 10mg

1-Butyl-2,3-dimethyl-1H-imidazol-3-ium hexafluorophosphate(V), 95.0%, 25g

3'-Fluoro-4'-(trifluoromethyl)acetophenone, 98.0%, 1g

Ethyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate, 98%, 1g